Medicines and Healthcare products Regulatory Agency

What's new

• 09 Feb 2010

  Problem with postal delivery of Yellow Cards

  We have identified a problem with the Yellow Card postal delivery service. Some Yellow Cards have been returned to sender due to an error at Royal Mail.

• 09 Feb 2010

  Important information on changes to the submission of Individual Case Safety Reports (ICSRs) for adverse drug reactions

  In order to support the MHRA's move to a paperless working environment from 1 March 2010, the MHRA will no longer be accepting paper Council for International Organizations of Medical Sciences (CIOMS) foms.

• 09 Feb 2010

  Public consultation (MLX 367): Proposals for amendments to the Prescription Only Medicines (Human Use) Order 1997 (the POM Order)

  This consultation seeks views on whether to amend the list of Prescription Only Medicines which can be administered parenterally by anyone for the purpose of saving life in an emergency under Article 7 of the POM Order.

• 09 Feb 2010

  Management and use of IVD point of care test devices - DB2010(02)

  This publication is a revised edition of our guidance on the management and use of point of care testing (POCT) in vitro diagnostic (IVD) devices.

• 08 Feb 2010

  Drug Safety Update: Volume 3, Issue 7, February 2010

  The February issue of ‘Drug Safety Update’ includes drug safety advice for the immunosuppressant tacrolimus, and an update on the obesity medicine orlistat.

• 08 Feb 2010

  Medical Device Alert: Servo 300 and 900 ventilators (SV300 and SV900) manufactured by Siemens (now Maquet) (MDA/2010/011)

  This Medical Device Alert has been issued due to excessive negative pressures (eg using closed suction systems), which can damage the inspiratory and expiratory pressure measurement transducers. Such damage has led to high gas flows that subsequently caused bilateral pneumothoraces.

• 05 Feb 2010

  Impersonation of MHRA staff

  We have become aware that there have been a number of calls made to companies recently from people purporting to be members of MHRA staff, but who do not work for the Agency.

• 01 Feb 2010

  Public consultation (MLX 366): Intention to amend the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 (SI 2008/1692)

  MLX 366 seeks your views on how current professional guidance can be expanded to provide additional support for community pharmacists following forthcoming legislative changes and also seeks views on any impact on businesses or equality issues.

• 01 Feb 2010

  Nicotine replacement therapy: New extended indication and consultation

  We have today announced an extended indication for nicotine replacement therapy (NRT) to include harm reduction, which has been granted for an (NRT) inhalator, available through general sales outlets.

• 01 Feb 2010

  Medical Device Alert: C-Max U/2 stair climbers manufactured by Alber Antriebstechnik GmbH (AAT) (MDA/2010/010)

  This Medical Device Alert (MDA) has been issued due to a risk of injury to the attendant's hand when using the climbing mechanism on C-Max U/2 stair climbers manufactured by Alber Antriebstechnik GmbH (AAT).